Credit: Celltrion

Ko­re­a's Cell­tri­on blue­prints $514M bi­o­log­ics plant in Chi­na, beef­ing up biosim­i­lar, con­tract man­u­fac­tur­ing

The Chi­nese city of Wuhan might have sprung to world­wide in­famy for the coro­n­avirus out­break orig­i­nat­ing from one of its seafood mar­kets, but if Cell­tri­on has its way, it will be­come known as a cen­ter of bi­o­log­ics man­u­fac­tur­ing.

The Ko­re­an biosim­i­lars mak­er has bud­get­ed $514 mil­lion (₩600 bil­lion) over five years for a new plant in Wuhan, which it says will be Chi­na’s biggest bi­o­log­ics fa­cil­i­ty at a ca­pac­i­ty of 120,000 liters. A ground­break­ing cer­e­mo­ny is slat­ed for April.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.